Vanags D M, Lloyd J V, Rodgers S E, Bochner F
Department of Clinical and Experimental Pharmacology, University of Adelaide, South Australia, Australia.
Eur J Pharmacol. 1998 Sep 25;358(1):93-100. doi: 10.1016/s0014-2999(98)00595-0.
Although adenosine diphosphate (ADP) is a well-known stimulus of platelet aggregation, it is not the generally accepted view that ADP stimulates phosphatidylinositolbisphosphate (PtdIns(4,5)P2) hydrolysis. Using a very sensitive competitive receptor binding assay for inositol 1,4,5-trisphosphate (Ins(1,4,5)P3), we have detected Ins(1,4,5)P3 production at early ( < 10 s) time points after stimulation of human platelets by the weak agonists ADP, adrenaline and serotonin (5-hydroxytryptamine, 5-HT). When adrenaline or 5-HT was combined with ADP in the presence of aspirin, there was a significant potentiation of ADP-induced platelet aggregation, but there was no potentiation of Ins(1,4,5)P3 generation. Also, the increases in intracellular calcium (Ca2+) concentrations stimulated by ADP were not potentiated by adrenaline in the presence of aspirin. Therefore, the synergism between the purinergic and adrenergic pathways of platelet activation occurs downstream from PtdIns(4,5)P2 hydrolysis and intracellular Ca2+ mobilization, although prior to platelet aggregation.
尽管二磷酸腺苷(ADP)是一种众所周知的血小板聚集刺激物,但ADP刺激磷脂酰肌醇-4,5-二磷酸(PtdIns(4,5)P2)水解这一观点并未得到普遍认可。我们使用一种针对肌醇1,4,5-三磷酸(Ins(1,4,5)P3)的高灵敏度竞争性受体结合测定法,检测到在弱激动剂ADP、肾上腺素和5-羟色胺(5-HT)刺激人血小板后的早期(<10秒)时间点有Ins(1,4,5)P3生成。当肾上腺素或5-HT在阿司匹林存在的情况下与ADP联合使用时,ADP诱导的血小板聚集有显著增强,但Ins(1,4,5)P3生成并无增强。此外,在阿司匹林存在的情况下,肾上腺素并未增强ADP刺激引起的细胞内钙(Ca2+)浓度升高。因此,血小板激活的嘌呤能和肾上腺素能途径之间的协同作用发生在PtdIns(4,5)P2水解和细胞内Ca2+动员下游,尽管在血小板聚集之前。